Literature DB >> 21932127

A differential diagnosis of central nervous system demyelination: beyond multiple sclerosis.

Christopher Eckstein1, Shiv Saidha, Michael Levy.   

Abstract

Although multiple sclerosis (MS) is the most common demyelinating disorder of the central nervous system (CNS), it lacks any definitive diagnostic test. Instead, diagnosis of MS primarily depends upon clinical criteria, supported by abnormalities characteristic of MS on para-clinical investigations including magnetic resonance imaging of the brain and spine, in the absence of an alternative explanation for underlying neurologic symptoms. While many of the potential disorders that may mimic MS in routine clinical practice are either extremely rare, or associated with specific and characteristic distinguishing diagnostic features, some inflammatory demyelinating disorders of the CNS may be particularly challenging to distinguish from MS, especially during initial presentation. In particular, acute disseminated encephalomyelitis, neuromyelitis optica, and idiopathic transverse myelitis may closely resemble MS, impeding prompt and accurate diagnosis. In this review, we describe the clinical features, diagnosis, pathology, and treatment of these other CNS demyelinating disorders. In addition, we review relevant features of other CNS inflammatory disorders that may mimic MS, including Sjögren's syndrome, systemic lupus erythematosus, Behçet's disease, and primary CNS vasculitis.

Entities:  

Mesh:

Year:  2011        PMID: 21932127     DOI: 10.1007/s00415-011-6240-5

Source DB:  PubMed          Journal:  J Neurol        ISSN: 0340-5354            Impact factor:   4.849


  141 in total

1.  ACUTE TRANSVERSE MYELOPATHY.

Authors:  P H ALTROCCHI
Journal:  Arch Neurol       Date:  1963-08

Review 2.  Criteria for diagnosis of Behçet's disease. International Study Group for Behçet's Disease.

Authors: 
Journal:  Lancet       Date:  1990-05-05       Impact factor: 79.321

3.  Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus.

Authors:  M C Hochberg
Journal:  Arthritis Rheum       Date:  1997-09

4.  Clinical patterns of neurological involvement in Behçet's disease: evaluation of 200 patients. The Neuro-Behçet Study Group.

Authors:  G Akman-Demir; P Serdaroglu; B Tasçi
Journal:  Brain       Date:  1999-11       Impact factor: 13.501

Review 5.  Primary angiitis of the CNS.

Authors:  Rula A Hajj-Ali; Aneesh B Singhal; Susanne Benseler; Eamonn Molloy; Leonard H Calabrese
Journal:  Lancet Neurol       Date:  2011-06       Impact factor: 44.182

Review 6.  Diagnosis and management of acute myelopathies.

Authors:  Adam I Kaplin; Chitra Krishnan; Deepa M Deshpande; Carlos A Pardo; Douglas A Kerr
Journal:  Neurologist       Date:  2005-01       Impact factor: 1.398

Review 7.  Acute transverse myelopathy complicating systemic lupus erythematosus.

Authors:  D J Propper; R C Bucknall
Journal:  Ann Rheum Dis       Date:  1989-06       Impact factor: 19.103

Review 8.  MRI and the brain in systemic lupus erythematosus.

Authors:  J W Graham; W Jan
Journal:  Lupus       Date:  2003       Impact factor: 2.911

Review 9.  Mycophenolate mofetil for induction therapy of lupus nephritis: a systematic review and meta-analysis.

Authors:  Michael Walsh; Matthew James; David Jayne; Marcello Tonelli; Braden J Manns; Brenda R Hemmelgarn
Journal:  Clin J Am Soc Nephrol       Date:  2007-08-08       Impact factor: 8.237

10.  Variable responses to rituximab treatment in neuromyelitis optica (Devic's disease).

Authors:  M Capobianco; S Malucchi; A di Sapio; F Gilli; A Sala; R Bottero; F Marnetto; C Doriguzzi Bozzo; A Bertolotto
Journal:  Neurol Sci       Date:  2007-08-10       Impact factor: 3.307

View more
  16 in total

Review 1.  Neuromyelitis optica spectrum disorders associated with other autoimmune diseases.

Authors:  Eduardo Freitas; Joana Guimarães
Journal:  Rheumatol Int       Date:  2014-06-22       Impact factor: 2.631

Review 2.  Multiple sclerosis update: use of MRI for early diagnosis, disease monitoring and assessment of treatment related complications.

Authors:  Mark S Igra; David Paling; Mike P Wattjes; Daniel J A Connolly; Nigel Hoggard
Journal:  Br J Radiol       Date:  2017-04-26       Impact factor: 3.039

3.  Variants in the promoter region of CYP7A1 are associated with neuromyelitis optica but not with multiple sclerosis in the Han Chinese population.

Authors:  Gui-Xian Zhao; Ying Liu; Zhen-Xin Li; Chuan-Zhen Lv; Anthony Traboulsee; A Dessa Sadovnick; Zhi-Ying Wu
Journal:  Neurosci Bull       Date:  2013-06-05       Impact factor: 5.203

4.  Acute necrotizing encephalopathy (ANE1): rare autosomal-dominant disorder presenting as acute transverse myelitis.

Authors:  Katharina Wolf; Thomas Schmitt-Mechelke; Spyridon Kollias; Armin Curt
Journal:  J Neurol       Date:  2013-01-18       Impact factor: 4.849

5.  Review of Animal Models of Neuromyelitis Optica.

Authors:  Melina V Jones; Nicolas Collongues; Jerome de Seze; Makoto Kinoshita; Yuji Nakatsuji; Michael Levy
Journal:  Mult Scler Relat Disord       Date:  2012-10       Impact factor: 4.339

6.  Cervical spinal demyelination with ethidium bromide impairs respiratory (phrenic) activity and forelimb motor behavior in rats.

Authors:  N L Nichols; A M Punzo; I D Duncan; G S Mitchell; R A Johnson
Journal:  Neuroscience       Date:  2012-11-14       Impact factor: 3.590

Review 7.  Differential diagnosis of white matter lesions: Nonvascular causes-Part II.

Authors:  S Weidauer; M Nichtweiss; E Hattingen
Journal:  Clin Neuroradiol       Date:  2014-02-12       Impact factor: 3.649

8.  Interleaved susceptibility-weighted and FLAIR MRI for imaging lesion-penetrating veins in multiple sclerosis.

Authors:  Refaat E Gabr; Amol S Pednekar; Arash Kamali; John A Lincoln; Flavia M Nelson; Jerry S Wolinsky; Ponnada A Narayana
Journal:  Magn Reson Med       Date:  2018-01-15       Impact factor: 4.668

Review 9.  Multiple sclerosis imaging: recent advances.

Authors:  Maria A Rocca; Roberta Messina; Massimo Filippi
Journal:  J Neurol       Date:  2012-12-21       Impact factor: 4.849

10.  Clinico-radiologic features and therapeutic strategies in tumefactive demyelination: a retrospective analysis of 50 consecutive cases.

Authors:  Aigli G Vakrakou; Dimitrios Tzanetakos; Maria-Eleptheria Evangelopoulos; Theodore Argyrakos; John S Tzartos; Maria Anagnostouli; Elissavet Andreadou; Georgios Koutsis; Georgios Velonakis; Panagiotis Toulas; Elias Gialafos; Antonios Dimitrakopoulos; Erasmia Psimenou; Leonidas Stefanis; Constantinos Kilidireas
Journal:  Ther Adv Neurol Disord       Date:  2021-05-18       Impact factor: 6.570

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.